Dr. Gary Van Heuvelen, MD

Dr. Van Heuvelen practices at Cancer Care Northwest - 1204 N Vercler Rd in Spokane Valley, Washington.

Dr. Van Heuvelen's NPI, 1629060256, was assigned on August 19, 2005. Dr. Van Heuvelen graduated from University of North Dakota School of Medicine in 1979. Dr. Van Heuvelen holds Idaho license M5310.

Dr. Van Heuvelen's primary practice is Cancer Care Northwest - 1204 N Vercler Rd, at 1204 N Vercler Rd, Spokane Valley, WA 99216 in Spokane County. The practice phone is (509) 228-1000.

Dr. Van Heuvelen's primary practice is Cancer Care Northwest - 1204 N Vercler Rd in Spokane Valley, Washington. Dr. Van Heuvelen is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is MultiCare Indigo Urgent Care, Spokane, Newport Hwy. Dmand AI also links Dr. Van Heuvelen to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Heuvelen practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Van Heuvelen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Van Heuvelen's licenses on file in 2 states: Idaho and Wyoming.

CMS data shows 4,782 Medicare services from Dr. Van Heuvelen across 18 procedure codes in 2024, for 343 Medicare patients. Medicare paid $213,000 for them. Every service was in an office.

CMS counts 343 Medicare patients who saw Dr. Van Heuvelen in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have cancer, and 66% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Heuvelen's median patient age at 74, with 50% women.

In 2024, Dr. Van Heuvelen wrote 23 Medicare Part D claims for 20 patients. 100% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $457 in total drug cost. In 2016, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Van Heuvelen for performance year 2024, reported as part of a group. Dr. Van Heuvelen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Van Heuvelen from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $147.

Dr. Van Heuvelen graduated from University of North Dakota School of Medicine in 1979.